This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murad, F. Search for Related Content PubMed PubMed Citation Articles by Murad, F.

(Circulation Research. 2003;92:339.)
© 2003 American Heart Association, Inc.

Editorials

The Excitement and Rewards of Research With Our Discovery of Some of the Biological Effects of Nitric Oxide

Ferid Murad

From the Department of Integrative Biology and Pharmacology and the Institute for Molecular Medicine, University of Texas, Houston.

Correspondence to Ferid Murad, MD, PhD, Professor and Chairman, Department of Integrative Biology and Pharmacology, University of Texas-Houston Medical School, MSB 4.098, PO Box 20708, Houston, TX 77225. E-mail Marcia.Waldbillig@uth.tmc.edu

Key Words: nitric oxide • cGMP • endothelial-derived relaxant factor • natriuretic peptides

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The rewards of biomedical research can be very exciting and remarkable. The feeling of having done an experiment for the first time and only you know the results that will have an important effect on your research and perhaps broader applications is exhilarating. I suspect that it is not common for scientists to see their fundamental research develop during their research career into such broad clinical application for numerous diseases. While much of our work and experiments were well planned, many of our important observations came from luck or serendipitous events—undoubtedly, a common phenomenon in biomedical research. I will recount some of these experiments here. A more detailed review can be found elsewhere.^1,2

I spent my early years as a trainee working with cAMP and adenylyl cyclase. As a result of this experience, after the discovery of cGMP in rat urine in the mid-1960s, I and others thought that cGMP might also be a second messenger to mediate the effects of some hormones and drugs. We transferred much of our work from cAMP to cGMP.

Our earliest experiments with guanylyl cyclase in the early 1970s suggested that there were at least two isoforms of the enzyme, soluble and particulate forms, with different kinetic properties.^3,4 This was of interest since adenylyl cyclase was exclusively particulate.⁵ The possibility of soluble and particulate isoforms of guanylyl cyclase suggested that different classes of hormones might regulate these different enzymes to produce separate pools of cGMP that may have different physiological effects. This was indeed . . . [Full Text of this Article]

This article has been cited by other articles:

				S. Y. Yuan New insights into eNOS signaling in microvascular permeability Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1029 - H1031. [Full Text] [PDF]